Dual role of macrophages in tumor growth and angiogenesis

Journal of Leukocyte Biology

Volumn 80, Issue 4, 2006, Pages 705-713

  Lamagna, Chrystelle ^a,b   Aurrand Lions, Michel ^a   Imhof, Beat A ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemokines; Monocytes; Neovascularization

Indexed keywords

CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 10; PERFORIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR ANTIGEN;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; CARCINOGENESIS; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONFERENCE PAPER; ENDOTHELIUM CELL; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; MACROPHAGE; NATURAL KILLER CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR IMMUNITY;

ANIMALS; HUMANS; MACROPHAGES; MODELS, BIOLOGICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 33751551172     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1105656     Document Type: Conference Paper

References (142)

1. Dunn, G. P., Old, L. J., Schreiber, R. D. (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137-148.
2. Lin, E. Y., Nguyen, A. V., Russell, R. G., Pollard, J. W. (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193, 727-740.
3. Condeelis, J., Pollard, J. W. (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263-266.
4. Dunn, G. P., Old, L. J., Schreiber, R. D. (2004) The three Es of cancer immunoediting. Annu. Rev. Immunol. 22, 329-360.
5. Fuchs, E. J., Matzinger, P. (1996) Is cancer dangerous to the immune system? Semin. Immunol. 8, 271-280.
6. Shinkai, Y., Rathbun, G., Lam, K. P., Oltz, E. M., Stewart, V., Mendelsohn, M., Charron, J., Datta, M., Young, F., Stall, A. M., et al. (1992) RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855-867.
7. Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., Schreiber, R. D. (2001) IFNγ and lymphocytes prevent primary tumor development and shape tumor immunogenicity. Nature 410, 1107-1111.
8. Dighe, A. S., Richards, E., Old, L. J., Schreiber, R. D. (1994) Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN γ receptors. Immunity 1, 447-456.
9. Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., Schreiber, R. D. (1998) Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95, 7556-7561.
10. Street, S. E., Trapani, J. A., MacGregor, D., Smyth, M. J. (2002) Suppression of lymphoma and epithelial malignancies effected by interferon γ. J. Exp. Med. 196, 129-134.
11. Street, S. E., Cretney, E., Smyth, M. J. (2001) Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis. Blood 97, 192-197.
12. Boehm, U., Klamp, T., Groot, M., Howard, J. C. (1997) Cellular responses to interferon-γ. Annu. Rev. Immunol. 15, 749-795.
13. Harris, D. P., Haynes, L., Sayles, P. C., Duso, D. K., Eaton, S. M., Lepak, N. M., Johnson, L. L., Swain, S. L., Lund, F. E. (2000) Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1, 475-482.
14. Munder, M., Mallo, M., Eichmann, K., Modolell, M. (1998) Murine macrophages secrete interferon γ upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J. Exp. Med. 187, 2103-2108.
15. Ibe, S., Qin, Z., Schuler, T., Preiss, S., Blankenstein, T. (2001) Tumor rejection by disturbing tumor stroma cell interactions. J. Exp. Med. 194, 1549-1559.
16. Gao, Y., Yang, W., Pan, M., Scully, E., Girardi, M., Augenlicht, L. H., Craft, J., Yin, Z. (2003) γ δ T cells provide an early source of interferon γ in tumor immunity. J. Exp. Med. 198, 433-442.
17. Smyth, M. J., Thia, K. Y., Street, S. E., MacGregor, D., Godfrey, D. I., Trapani, J. A. (2000) Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J. Exp. Med. 192, 755-760.
18. Van den Broek, M. E., Kagi, D., Ossendorp, F., Toes, R., Vamvakas, S., Lutz, W. K., Melief, C. J., Zinkernagel, R. M., Hengartner, H. (1996) Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 184, 1781-1790.
19. Marincola, F. M., Jaffee, E. M., Hicklin, D. J., Ferrone, S. (2000) Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv. Immunol. 74, 181-273.
20. Seliger, B., Maeurer, M. J., Ferrone, S. (2000) Antigen-processing machinery breakdown and tumor growth. Immunol. Today 21, 455-464.
21. Gabrilovich, D. (2004) Mechanisms and functional significance of tumor-induced dendritic-cell defects. Nat. Rev. Immunol. 4, 941-952.
22. Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., Dalton, W., Jove, R., Pardoll, D., Yu, H. (2004) Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat. Med. 10, 48-54.
23. Khong, H. T., Restifo, N. P. (2002) Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat. Immunol. 3, 999-1005.
24. Zou, W. (2006) Regulatory T cells, tumor immunity and immunotherapy. Nat. Rev. Immunol. 6, 295-307.
25. Balkwill, F., Mantovani, A. (2001) Inflammation and cancer: back to Virchow? Lancet 357, 539-545.
26. Sica, A., Schioppa, T., Mantovani, A., Allavena, P. (2006) Tumor-associated macrophages are a distinct M2 polarized population promoting tumor progression: potential targets of anti-cancer therapy. Eur. J. Cancer 42, 717-727.
27. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555.
28. Lewis, C. E., Pollard, J. W. (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66, 605-612.
29. Nakao, S., Kuwano, T., Tsutsumi-Miyahara, C., Ueda, S., Kimura, Y. N., Hamano, S., Sonoda, K. H., Saijo, Y., Nukiwa, T., Strieter, R. M., Ishibashi, T., Kuwano, M., Ono, M. (2005) Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 β-induced neovascularization and tumor growth. J. Clin. Invest. 115, 2979-2991.
30. Imhof, B. A., Aurrand-Lions, M. (2004) Adhesion mechanisms regulating the migration of monocytes. Nat. Rev. Immunol. 4, 432-444.
31. Nathan, C. F. (1987) Secretory products of macrophages. J. Clin. Invest. 79, 319-326.
32. Gordon, S. (2002) Pattern recognition receptors: doubling up for the innate immune response. Cell 111, 927-930.
33. Mantovani, A., Allavena, P., Sica, A. (2004) Tumor-associated macrophages as a prototypic type II polarized phagocyte population: role in tumor progression. Eur. J. Cancer 40, 1660-1667.
34. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
35. Goede, V., Brogelli, L., Ziche, M., Augustin, H. G. (1999) Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int. J. Cancer 82, 765-770.
36. Luboshits, G., Shina, S., Kaplan, O., Engelberg, S., Nass, D., Lifshitz-Mercer, B., Chaitchik, S., Keydar, I., Ben-Baruch, A. (1999) Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res. 59, 4681-4687.
37. Bottazzi, B., Polentarutti, N., Acero, R., Balsari, A., Boraschi, D., Ghezzi, P., Salmona, M., Mantovani, A. (1983) Regulation of the macrophage content of neoplasms by chemoattractants. Science 220, 210-212.
38. Low, Q. E., Drugea, I. A., Duffner, L. A., Quinn, D. G., Cook, D. N., Rollins, B. J., Kovacs, E. J., DiPietro, L. A. (2001) Wound healing in MIP-1α(-/-) and MCP-1(-/-) mice. Am. J. Pathol. 159, 457-463.
39. Lu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., Rollins, B. J. (1998) Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187, 601-608.
40. Tsutsumi, C., Sonoda, K. H., Egashira, K., Qiao, H., Hisatomi, T., Nakao, S., Ishibashi, M., Charo, I. F., Sakamoto, T., Murata, T., Ishibashi, T. (2003) The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J. Leukoc. Biol. 74, 25-32.
41. Nesbit, M., Schaider, H., Miller, T. H., Herlyn, M. (2001) Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J. Immunol. 166, 6483-6490.
42. Azenshtein, E., Luboshits, G., Shina, S., Neumark, E., Shahbazian, D., Weil, M., Wigler, N., Keydar, I., Ben-Baruch, A. (2002) The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res. 62, 1093-1102.
43. Locati, M., Deuschle, U., Massardi, M. L., Martinez, F. O., Sironi, M., Sozzani, S., Bartfai, T., Mantovani, A. (2002) Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J. Immunol. 168, 3557-3562.
44. Rot, A., von Andrian, U. H. (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22, 891-928.
45. Milliken, D., Scotton, C., Raju, S., Balkwill, F., Wilson, J. (2002) Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites. Clin. Cancer Res. 8, 1108-1114.
46. Scotton, C., Milliken, D., Wilson, J., Raju, S., Balkwill, F. (2001) Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumors. Br. J. Cancer 85, 891-897.
47. Schutyser, E., Struyf, S., Proost, P., Opdenakker, G., Laureys, G., Verhasselt, B., Peperstraete, L., Van de Putte, I., Saccani, A., Allavena, P., Mantovani, A., Van Damme, J. (2002) Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma. J. Biol. Chem. 277, 24584-24593.
48. Cecchini, M. G., Dominguez, M. G., Mocci, S., Wetterwald, A., Felix, R., Fleisch, H., Chisholm, O., Hofstetter, W., Pollard, J. W., Stanley, E. R. (1994) Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 120, 1357-1372.
49. Rambaldi, A., Young, D. C., Griffin, J. D. (1987) Expression of the M-CSF (CSF-1) gene by human monocytes. Blood 69, 1409-1413.
50. Leek, R. D., Hunt, N. C., Landers, R. J., Lewis, C. E., Royds, J. A., Harris, A. L. (2000) Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J. Pathol. 190, 430-436.
51. Barleon, B., Sozzani, S., Zhou, D., Weich, H. A., Mantovani, A., Marme, D. (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87, 3336-3343.
52. Sawano, A., Iwai, S., Sakurai, Y., Ito, M., Shitara, K., Nakahata, T., Shibuya, M. (2001) Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97, 785-791.
53. Hiratsuka, S., Minowa, O., Kuno, J., Noda, T., Shibuya, M. (1998) Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA 95, 9349-9354.
54. Grunewald, M., Avraham, I., Dor, Y., Bachar-Lustig, E., Itin, A., Yung, S., Chimenti, S., Landsman, L., Abramovitch, R., Keshet, E. (2006) VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124, 175-189.
55. Murdoch, C., Giannoudis, A., Lewis, C. E. (2004) Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104, 2224-2234.
56. Masaki, T., Miwa, S., Sawamura, T., Ninomiya, H., Okamoto, Y. (1999) Subcellular mechanisms of endothelin action in vascular system. Eur. J. Pharmacol. 375, 133-138.
57. Grant, K., Loizidou, M., Taylor, I. (2003) Endothelin-1: a multifunctional molecule in cancer. Br. J. Cancer 88, 163-166.
58. Cui, P., Tani, K., Kitamura, H., Okumura, Y., Yano, M., Inui, D., Tamaki, T., Sone, S., Kido, H. (2001) A novel bioactive 31-amino acid endothelin-1 is a potent chemotactic peptide for human neutrophils and monocytes. J. Leukoc. Biol. 70, 306-312.
59. Grimshaw, M. J., Wilson, J. L., Balkwill, F. R. (2002) Endothelin-2 is a macrophage chemoattractant: implications for macrophage distribution in tumors. Eur. J. Immunol. 32, 2393-2400.
60. Grimshaw, M. J., Hagemann, T., Ayhan, A., Gillett, C. E., Binder, C., Balkwill, F. R. (2004) A role for endothelin-2 and its receptors in breast tumor cell invasion. Cancer Res. 64, 2461-2468.
61. Mantovani, A. (1994) Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab. Invest. 71, 5-16.
62. Tsung, K., Dolan, J. P., Tsung, Y. L., Norton, J. A. (2002) Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. Cancer Res. 62, 5069-5075.
63. Brigati, C., Noonan, D. M., Albini, A., Benelli, R. (2002) Tumors and inflammatory infiltrates: friends or foes? Clin. Exp. Metastasis 19, 247-258.
64. Bancroft, G. J., Schreiber, R. D., Unanue, E. R. (1991) Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol. Rev. 124, 5-24.
65. Chan, C. W., Crafton, E., Fan, H. N., Flook, J., Yoshimura, K., Skarica, M., Brockstedt, D., Dubensky, T. W., Stins, M. F., Lanier, L. L., Pardoll, D. M., Housseau, F. (2006) Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12, 207-213.
66. Taieb, J., Chaput, N., Menard, C., Apetoh, L., Ullrich, E., Bonmort, M., Pequignot, M., Casares, N., Terme, M., Flament, C., et al. (2006) A novel dendritic cell subset involved in tumor immunosurveillance. Nat. Med. 12, 214-219.
67. MacMicking, J., Xie, Q. W., Nathan, C. (1997) Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323-350.
68. Blankenstein, T., Qin, Z. H., Uberla, K., Muller, W., Rosen, H., Volk, H. D., Diamantstein, T. (1991) Tumor suppression after tumor cell-targeted tumor necrosis factor α gene transfer. J. Exp. Med. 173, 1047-1052.
69. McBride, W. H. (1986) Phenotype and functions of intratumoral macrophages. Biochim. Biophys. Acta 865, 27-41.
70. Coussens, L. M., Tinkle, C. L., Hanahan, D., Werb, Z. (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481-490.
71. Nowicki, A., Szenajch, J., Ostrowska, G., Wojtowicz, A., Wojtowicz, K., Kruszewski, A. A., Maruszynski, M., Aukerman, S. L., Wiktor-Jedrzejczak, W. (1996) Impaired tumor growth in colony-stimulating factor 1 (CSF-1)-deficient, macrophage-deficient op/op mouse: evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma. Int. J. Cancer 65, 112-119.
72. Bingle, L., Brown, N. J., Lewis, C. E. (2002) The role of tumor-associated macrophages in tumor progression: implications for new anticancer therapies. J. Pathol. 196, 254-265.
73. Coussens, L. M., Werb, Z. (1996) Matrix metalloproteinases and the development of cancer. Chem. Biol. 3, 895-904.
74. Eccles, S. A., Alexander, P. (1974) Macrophage content of tumors in relation to metastatic spread and host immune reaction. Nature 250, 667-669.
75. Robinson, S. C., Scott, K. A., Balkwill, F. R. (2002) Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-α. Eur. J. Immunol. 32, 404-412.
76. Maruyama, K., Ii, M., Cursiefen, C., Jackson, D. G., Keino, H., Tomita, M., Van Rooijen, N., Takenaka, H., D'Amore, P. A., Stein-Streilein, J., Losordo, D. W., Streilein, J. W. (2005) Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J. Clin. Invest. 115, 2363-2372.
77. Schoppmann, S. F., Birner, P., Stockl, J., Kalt, R., Ullrich, R., Caucig, C., Kriehuber, E., Nagy, K., Alitalo, K., Kerjaschki, D. (2002) Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol. 161, 947-956.
78. Torisu, H., Ono, M., Kiryu, H., Furue, M., Ohmoto, Y., Nakayama, J., Nishioka, Y., Sone, S., Kuwano, M. (2000) Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFα and IL-1α. Int. J. Cancer 85, 182-188.
79. Helmlinger, G., Netti, P. A., Lichtenbeld, H. C., Melder, R. J., Jain, R. K. (1997) Solid stress inhibits the growth of multicellular tumor spheroids. Nat. Biotechnol. 15, 778-783.
80. Chang, Y. S., di Tomaso, E., McDonald, D. M., Jones, R., Jain, R. K., Munn, L. L. (2000) Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc. Natl. Acad. Sci. USA 97, 14608-14613.
81. Lewis, C. E., Leek, R., Harris, A., McGee, J. O. (1995) Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J. Leukoc. Biol. 57, 747-751.
82. Kahaleh, M. B., DeLustro, F., Bock, W., LeRoy, E. C. (1986) Human monocyte modulation of endothelial cells and fibroblast growth: possible mechanism for fibrosis. Clin. Immunol. Immunopathol. 39, 242-255.
83. Vilette, D., Setiadi, H., Wautier, M. P., Caen, J., Wautier, J. L. (1990) Identification of an endothelial cell growth-inhibitory activity produced by human monocytes. Exp. Cell Res. 188, 219-225.
84. Pakala, R., Watanabe, T., Benedict, C. R. (2002) Induction of endothelial cell proliferation by angiogenic factors released by activated monocytes. Cardiovasc. Radiat. Med. 3, 95-101.
85. Salvesen, H. B., Akslen, L. A. (1999) Significance of tumor-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumor angiogenesis and prognosis in endometrial carcinomas. Int. J. Cancer 84, 538-543.
86. Takanami, I., Takeuchi, K., Kodaira, S. (1999) Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis. Oncology 57, 138-142.
87. Polverini, P. J., Cotran, P. S., Gimbrone Jr., M. A., Unanue, E. R. (1977) Activated macrophages induce vascular proliferation. Nature 269, 804-806.
88. Sunderkotter, C., Goebeler, M., Schulze-Osthoff, K., Bhardwaj, R., Sorg, C. (1991) Macrophage-derived angiogenesis factors. Pharmacol. Ther. 51, 195-216.
89. Xiong, M., Elson, G., Legarda, D., Leibovich, S. J. (1998) Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am. J. Pathol. 153, 587-598.
90. Ramos, M. A., Kuzuya, M., Esaki, T., Miura, S., Satake, S., Asai, T., Kanda, S., Hayashi, T., Iguchi, A. (1998) Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 18, 1188-1196.
91. Wang, N., Tabas, I., Winchester, R., Ravalli, S., Rabbani, L. E., Tall, A. (1996) Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J. Biol. Chem. 271, 8837-8842.
92. Itaya, H., Imaizumi, T., Yoshida, H., Koyama, M., Suzuki, S., Satoh, K. (2001) Expression of vascular endothelial growth factor in human monocyte/macrophages stimulated with lipopolysaccharide. Thromb. Haemost. 85, 171-176.
93. Dougherty, S. T., Eaves, C. J., McBride, W. H., Dougherty, G. J. (1997) Role of macrophage-colony-stimulating factor in regulating the accumulation and phenotype of tumor-associated macrophages. Cancer Immunol. Immunother. 44, 165-172.
94. Eubank, T. D., Galloway, M., Montague, C. M., Waldman, W. J., Marsh, C. B. (2003) M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes. J. Immunol. 171, 2637-2643.
95. Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., Oft, M. (2006) IL-23 promotes tumor incidence and growth. Nature, Epub ahead of print.
96. Numasaki, M., Fukushi, J., Ono, M., Narula, S. K., Zavodny, P. J., Kudo, T., Robbins, P. D., Tahara, H., Lotze, M. T. (2003) Interleukin-17 promotes angiogenesis and tumor growth. Blood 101, 2620-2627.
97. Leek, R. D., Landers, R. J., Harris, A. L., Lewis, C. E. (1999) Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br. J. Cancer 79, 991-995.
98. Lewis, J. S., Landers, R. J., Underwood, J. C., Harris, A. L., Lewis, C. E. (2000) Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J. Pathol. 192, 150-158.
99. Onita, T., Ji, P. G., Xuan, J. W., Sakai, H., Kanetake, H., Maxwell, P. H., Fong, G. H., Gabril, M. Y., Moussa, M., Chin, J. L. (2002) Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia- inducible factor-2α correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer. Clin. Cancer Res. 8, 471-480.
100. Metinko, A. P., Kunkel, S. L., Standiford, T. J., Strieter, R. M. (1992) Anoxia-hyperoxia induces monocyte-derived interleukin-8. J. Clin. Invest. 90, 791-798.
101. Harmey, J. H., Dimitriadis, E., Kay, E., Redmond, H. P., Bouchier-Hayes, D. (1998) Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor β-1. Ann. Surg. Oncol. 5, 271-278.
102. Kuwabara, K., Ogawa, S., Matsumoto, M., Koga, S., Clauss, M., Pinsky, D. J., Lyn, P., Leavy, J., Witte, L., Joseph-Silverstein, J., et al. (1995) Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc. Natl. Acad. Sci. USA 92, 4606-4610.
103. Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., Mantovani, A., Melillo, G., Sica, A. (2003) Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198, 1391-1402.
104. Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., Gurtner, G. C. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10, 858-864.
105. Pugh, C. W., Ratcliffe, P. J. (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9, 677-684.
106. Talks, K. L., Turley, H., Gatter, K. C., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., Harris, A. L. (2000) The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 157, 411-421.
107. Burke, B., Tang, N., Corke, K. P., Tazzyman, D., Ameri, K., Wells, M., Lewis, C. E. (2002) Expression of HIF-1α by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J. Pathol. 196, 204-212.
108. Ingber, D. E. (1992) Extracellular matrix as a solid-state regulator in angiogenesis: identification of new targets for anti-cancer therapy. Semin. Cancer Biol. 3, 57-63.
109. Sabapathy, K. T., Pepper, M. S., Kiefer, F., Mohle-Steinlein, U., Tacchini-Cottier, F., Fetka, I., Breier, G., Risau, W., Carmeliet, P., Montesano, R., Wagner, E. F. (1997) Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/plasmin system. J. Cell Biol. 137, 953-963.
110. Ribatti, D., Leali, D., Vacca, A., Giuliani, R., Gualandris, A., Roncali, L., Nolli, M. L., Presta, M. (1999) In vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2. J. Cell Sci. 112, 4213-4221.
111. Taipale, J., Keski-Oja, J. (1997) Growth factors in the extracellular matrix. FASEB J. 11, 51-59.
112. Flaumenhaft, R., Abe, M., Mignatti, P., Rifkin, D. B. (1992) Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: regulation of plasminogen activator activity. J. Cell Biol. 118, 901-909.
113. DeClerck, Y. A., Mercurio, A. M., Stack, M. S., Chapman, H. A., Zutter, M. M., Muschel, R. J., Raz, A., Matrisian, L. M., Sloane, B. F., Noel, A., Hendrix, M. J., Coussens, L., Padarathsingh, M. (2004) Proteases, extracellular matrix, and cancer: a workshop of the path B study section. Am. J. Pathol. 164, 1131-1139.
114. Demetri, G. D., Griffin, J. D. (1991) Granulocyte colony-stimulating factor and its receptor. Blood 78, 2791-2808.
115. Dong, Z., Kumar, R., Yang, X., Fidler, I. J. (1997) Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88, 801-810.
116. Cao, Y., Ji, R. W., Davidson, D., Schaller, J., Marti, D., Sohndel, S., McCance, S. G., O'Reilly, M. S., Llinas, M., Folkman, J. (1996) Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J. Biol. Chem. 271, 29461-29467.
117. Schulze-Osthoff, K., Risau, W., Vollmer, E., Sorg, C. (1990) In situ detection of basic fibroblast growth factor by highly specific antibodies. Am. J. Pathol. 137, 85-92.
118. Berse, B., Brown, L. F., Van de Water, L., Dvorak, H. F., Senger, D. R. (1992) Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 3, 211-220.
119. Chervenick, P. A., LoBuglio, A. F. (1972) Human blood monocytes: stimulators of granulocyte and mononuclear colony formation in vitro. Science 178, 164-166.
120. Sullivan, R., Gans, P. J., McCarroll, L. A. (1983) The synthesis and secretion of granulocyte-monocyte colony-stimulating activity (CSA) by isolated human monocytes: kinetics of the response to bacterial endotoxin. J. Immunol. 130, 800-807.
121. Crowther, M., Brown, N. J., Bishop, E. T., Lewis, C. E. (2001) Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J. Leukoc. Biol. 70, 478-490.
122. Varney, M. L., Olsen, K. J., Mosley, R. L., Bucana, C. D., Talmadge, J. E., Singh, R. K. (2002) Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis. In Vivo 16, 471-477.
123. Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., Strieter, R. M. (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258, 1798-1801.
124. Pepper, M. S., Belin, D., Montesano, R., Orci, L., Vassalli, J. D. (1990) Transforming growth factor-β 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol. 111, 743-755.
125. Robinson, B. W., McLemore, T. L., Crystal, R. G. (1985) γ Interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J. Clin. Invest. 75, 1488-1495.
126. Rappolee, D. A., Mark, D., Banda, M. J., Werb, Z. (1988) Wound macrophages express TGF-α and other growth factors in vivo: analysis by mRNA phenotyping. Science 241, 708-712.
127. Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., Nuseir, N. (1987) Macrophage-induced angiogenesis is mediated by tumor necrosis factor-α. Nature 329, 630-632.
128. Byfield, S. D., Roberts, A. B. (2004) Lateral signaling enhances TGF-β response complexity. Trends Cell Biol. 14, 107-111.
129. Osthoff, K. S., Fruhbeis, B., Overwien, B., Hilbig, B., Sorg, C. (1987) Purification and characterization of a novel human angiogenic factor (h-AF). Biochem. Biophys. Res. Commun. 146, 945-952.
130. Fruhbeis, B., Zwadlo, G., Brocker, E. B., Osthoff, K. S., Hagemeier, H. H., Topoll, H., Sorg, C. (1988) Immunolocalization of an angiogenic factor (HAF) in normal, inflammatory and tumor tissues. Int. J. Cancer 42, 207-212.
131. Hockel, M., Sasse, J., Wissler, J. H. (1987) Purified monocyte-derived angiogenic substance (angiotropin) stimulates migration, phenotypic changes, and "tube formation" but not proliferation of capillary endothelial cells in vitro. J. Cell. Physiol. 133, 1-13.
132. Hockel, M., Jung, W., Vaupel, P., Rabes, H., Khaledpour, C., Wissler, J. H. (1988) Purified monocyte-derived angiogenic substance (angiotropin) induces controlled angiogenesis associated with regulated tissue proliferation in rabbit skin. J. Clin. Invest. 82, 1075-1090.
133. Hockel, M., Burke, J. F. (1989) Angiotropin treatment prevents flap necrosis and enhances dermal regeneration in rabbits. Arch. Surg. 124, 693-698.
134. Vignaud, J. M., Marie, B., Klein, N., Plenat, F., Pech, M., Borrelly, J., Martinet, N., Duprez, A., Martinet, Y. (1994) The role of platelet-derived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer. Cancer Res. 54, 5455-5463.
135. Enge, M., Bjarnegard, M., Gerhardt, H., Gustafsson, E., Kalen, M., Asker, N., Hammes, H. P., Shani, M., Fassler, R., Betsholtz, C. (2002) Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J. 21, 4307-4316.
136. Hirschi, K. K., Rohovsky, S. A., Beck, L. H., Smith, S. R., D'Amore, P. A. (1999) Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ. Res. 84, 298-305.
137. Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A., Betsholtz, C. (1999) Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126, 3047-3055.
138. Armulik, A., Abramsson, A., Betsholtz, C. (2005) Endothelial/pericyte interactions. Circ. Res. 97, 512-523.
139. Leveen, P., Pekny, M., Gebre-Medhin, S., Swolin, B., Larsson, E., Betsholtz, C. (1994) Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8, 1875-1887.
140. Lindahl, P., Johansson, B. R., Leveen, P., Betsholtz, C. (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277, 242-245.
141. Soriano, P. (1994) Abnormal kidney development and hematological disorders in PDGF β-receptor mutant mice. Genes Dev. 8, 1888-1896.
142. Uutela, M., Wirzenius, M., Paavonen, K., Rajantie, I., He, Y., Karpanen, T., Lohela, M., Wiig, H., Salven, P., Pajusola, K., Eriksson, U., Alitalo, K. (2004) PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. Blood 104, 3198-3204.